RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/38849061/ below:

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024

doi: 10.1016/j.jclinepi.2024.111422. Epub 2024 Jul 9. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024 Lidwine B Mokkink², Caroline B Terwee², Dorcas Beaton³, Joel J Gagnier⁴, Andrea C Tricco⁵, Ami Baba⁶, Nancy J Butcher⁷, Maureen Smith⁸, Catherine Hofstetter⁹, Olalekan Lee Aiyegbusi¹⁰, Anna Berardi¹¹, Julie Farmer¹², Kirstie L Haywood¹³, Karolin R Krause¹⁴, Sarah Markham¹⁵, Evan Mayo-Wilson¹⁶, Ava Mehdipour¹⁷, Juanna Ricketts¹⁸, Peter Szatmari¹⁴, Zahi Touma¹⁹, David Moher²⁰, Martin Offringa²¹

Affiliations

¹ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada; Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
² Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
³ Institute of Work and Health, Toronto, Ontario, Canada.
⁴ Department of Epidemiology & Biostatistics, Western University, London, Ontario, Canada.
⁵ Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
⁶ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
⁷ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
⁸ Cochrane Consumer Network, London, UK.
⁹ OMERACT Patient Research Partner, Toronto, Ontario, Canada.
¹⁰ Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
¹¹ Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; IRCCS NEUROMED, Pozzilli, Isernia, Italy.
¹² Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
¹³ Warwick Research in Nursing, Division of Health Sciences, Warwick Medical School, University of Warwick, Gibbet Hill, Coventry, UK.
¹⁴ Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
¹⁵ Department of Biostatistics & Health Informatics, Institute of Psychiatry Psychology & Neuroscience (IoPPN), King's College London, London, UK.
¹⁶ Department of Epidemiology, UNC Gillings School of Global Public Health, 2101C McGavran-Greenberg Hall Chapel Hill, Chapel Hill, NC 27599, USA.
¹⁷ School of Rehabilitation Science, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
¹⁸ Patient Partner, Halifax, Nova Scotia, Canada.
¹⁹ Division of Rheumatology, Schroeder Arthritis Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
²⁰ Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
²¹ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. Electronic address: martin.offringa@sickkids.ca.

PMID: 38849061
DOI: 10.1016/j.jclinepi.2024.111422

Free article

Item in Clipboard

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024

Ellen B M Elsman et al. J Clin Epidemiol. 2024 Sep.

Free article doi: 10.1016/j.jclinepi.2024.111422. Epub 2024 Jul 9. Authors Ellen B M Elsman¹, Lidwine B Mokkink², Caroline B Terwee², Dorcas Beaton³, Joel J Gagnier⁴, Andrea C Tricco⁵, Ami Baba⁶, Nancy J Butcher⁷, Maureen Smith⁸, Catherine Hofstetter⁹, Olalekan Lee Aiyegbusi¹⁰, Anna Berardi¹¹, Julie Farmer¹², Kirstie L Haywood¹³, Karolin R Krause¹⁴, Sarah Markham¹⁵, Evan Mayo-Wilson¹⁶, Ava Mehdipour¹⁷, Juanna Ricketts¹⁸, Peter Szatmari¹⁴, Zahi Touma¹⁹, David Moher²⁰, Martin Offringa²¹ Affiliations

¹ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada; Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
² Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
³ Institute of Work and Health, Toronto, Ontario, Canada.
⁴ Department of Epidemiology & Biostatistics, Western University, London, Ontario, Canada.
⁵ Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, Canada.
⁶ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
⁷ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
⁸ Cochrane Consumer Network, London, UK.
⁹ OMERACT Patient Research Partner, Toronto, Ontario, Canada.
¹⁰ Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
¹¹ Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; IRCCS NEUROMED, Pozzilli, Isernia, Italy.
¹² Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
¹³ Warwick Research in Nursing, Division of Health Sciences, Warwick Medical School, University of Warwick, Gibbet Hill, Coventry, UK.
¹⁴ Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
¹⁵ Department of Biostatistics & Health Informatics, Institute of Psychiatry Psychology & Neuroscience (IoPPN), King's College London, London, UK.
¹⁶ Department of Epidemiology, UNC Gillings School of Global Public Health, 2101C McGavran-Greenberg Hall Chapel Hill, Chapel Hill, NC 27599, USA.
¹⁷ School of Rehabilitation Science, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
¹⁸ Patient Partner, Halifax, Nova Scotia, Canada.
¹⁹ Division of Rheumatology, Schroeder Arthritis Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
²⁰ Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
²¹ Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. Electronic address: martin.offringa@sickkids.ca.

PMID: 38849061
DOI: 10.1016/j.jclinepi.2024.111422

Item in Clipboard

Abstract

Background and objective: Although comprehensive and widespread guidelines on how to conduct systematic reviews of outcome measurement instruments (OMIs) exist, for example from the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) initiative, key information is often missing in published reports. This article describes the development of an extension of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guideline: PRISMA-COSMIN for OMIs 2024.

Methods: The development process followed the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines and included a literature search, expert consultations, a Delphi study, a hybrid workgroup meeting, pilot testing, and an end-of-project meeting, with integrated patient/public involvement.

Results: From the literature and expert consultation, 49 potentially relevant reporting items were identified. Round 1 of the Delphi study was completed by 103 panelists, whereas round 2 and 3 were completed by 78 panelists. After 3 rounds, agreement (≥67%) on inclusion and wording was reached for 44 items. Eleven items without consensus for inclusion and/or wording were discussed at a workgroup meeting attended by 24 participants. Agreement was reached for the inclusion and wording of 10 items, and the deletion of 1 item. Pilot testing with 65 authors of OMI systematic reviews further improved the guideline through minor changes in wording and structure, finalized during the end-of-project meeting. The final checklist to facilitate the reporting of full systematic review reports contains 54 (sub)items addressing the review's title, abstract, plain language summary, open science, introduction, methods, results, and discussion. Thirteen items pertaining to the title and abstract are also included in a separate abstract checklist, guiding authors in reporting for example conference abstracts.

Conclusion: PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs, fostering their reproducibility and allowing end-users to appraise the quality of OMIs and select the most appropriate OMI for a specific application. NOTE: This paper was jointly developed by Journal of Clinical Epidemiology, Quality of Life Research, Journal of Patient Reported Outcomes, Health and Quality of Life Outcomes and jointly published by Elsevier Inc, Springer Nature Switzerland AG, and BioMed Central Ltd., part of Springer Nature. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either citation can be used when citing this article.

Keywords: COSMIN; Measurement properties; Outcome measurement instrument; PRISMA; Reporting guideline; Systematic reviews.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Drs Terwee and Mokkink are the founders of COSMIN; Dr Moher is a member of the PRISMA executive; Dr Tricco is the co-editor in chief of the Journal of Clinical Epidemiology. The other authors have no conflicts of interest.